ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Xylonix Reveals New Drug Compound for Combating Cancer and Abnormal Macrophages
March 23, 2021Xylonix, a Singapore-based biotech company, has developed a new immunity drug (010DS-Zn) that demonstrates potential for treating a variety of solid cancers and COVID-19's post-recovery complications, which include heart damage, diabetes and ... -
Xylonix, Biogemex to co-develop predictive cancer immunotherapy
August 18, 2019XDX-01, a novel, point-of-care pre-treatment diagnostic, has completed early validation studies, predicting patient responses (PFS, ORR) to cancer immunotherapies
Pharma Sources Insight January 2025
